巴西人胰岛素公共融资数据集:2009-2017
巴西2009-2017年胰岛素公共融资数据,包括预算、价格及使用量,用于糖尿病治疗政策分析。

基本信息
资源简介
巴西人胰岛素公共融资数据集:2009-2017
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 4 个文件、合计 22.53 KB,主题涵盖 Diabetes mellitus、Insulin、Healthcare financing、Supply、Drug price,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Public financing of human insulins in Brazil: 2009-2017》。配套论文《Public financing of human insulins in Brazil: 2009-2017》发表于 Revista Brasileira de Epidemiologia(2020),DOI:10.1590/1980-549720200075。源站首次发布:2021-03-26。
【数据内容】
源站原始描述:ABSTRACT: Background: From 2006 to 2017, the Brazilian federal government provided free of charge traditional insulins for diabetes treatment. This involved public tendering by the Department of Health Logistics of the Ministry of Health (DLOG-MOH) and the reimbursement after direct contracting for supply with commercial private retailers (Brazilian Popular Pharmacy Program - PFPB). Objective: We aim to describe the budget of the Brazilian federal government committed to for the acquisition of i…
【数据结构与技术规格】
文件数 4 个,合计 22.53 KB。数据集 DOI:10.6084/m9.figshare.14321451.v1。
【主题与分类】
源站学科分类:Environmental and Occupational Health and Safety。主题标签:Diabetes mellitus、Insulin、Healthcare financing、Supply、Drug price。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://scielo.figshare.com/articles/dataset/Public_financing_of_human_insulins_in_Brazil_2009-2017/14321451
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Dias, Leticia Lucia dos Santos; Santos, Maria Angelica Borges dos; Osorio-de-Castro, Claudia Garcia Serpa (2020). Public financing of human insulins in Brazil: 2009-2017. SciELO journals. Dataset
【使用注意】
· 源站最后修改于 2023-05-31,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Public financing of human insulins in Brazil: 2009-2017
- DOI:10.6084/m9.figshare.14321451.v1
- 发布日期:2021-03-26
- 文件数:4 个
- 文件总体积:22.53 KB
- 源站页面:https://scielo.figshare.com/articles/dataset/Public_financing_of_human_insulins_in_Brazil_2009-2017/14321451
命令行下载
curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/27274842"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/27274848"
curl -L -o "Table_3.xls" "https://ndownloader.figshare.com/files/27274851"
curl -L -o "Table_4.xls" "https://ndownloader.figshare.com/files/27274854"
文件清单
Table_1.xls(5.63 KB)Table_2.xls(5.63 KB)Table_3.xls(5.63 KB)Table_4.xls(5.63 KB)
文件总体积 22.53 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
ABSTRACT: Background: From 2006 to 2017, the Brazilian federal government provided free of charge traditional insulins for diabetes treatment. This involved public tendering by the Department of Health Logistics of the Ministry of Health (DLOG-MOH) and the reimbursement after direct contracting for supply with commercial private retailers (Brazilian Popular Pharmacy Program - PFPB). Objective: We aim to describe the budget of the Brazilian federal government committed to for the acquisition of insulin, as well as corresponding prices and treatment availability from 2009 to 2017. Methods: Insulin volume and expenditure data were obtained in official administrative databases and in the Electronic System of the Information Service to Citizens. Data were analyzed according to the total provision by the federal government, DLOG-MOH and PFPB. Moreover, data were presented according to insulin type. Volumes were calculated in number of defined daily doses (DDD)/1,000 inhabitants/day. Results: Budgetary commitments due to insulin over nine years amounted to U$1,027 billion in 2017, with an approximate average of U$114.1 million per year. DLOG-MOH was the main insulin provider, despite the increase in PFPB provision along period. DLOG-MOH and PFBP together provided an average of 6.08 DDD/1000 inhabitants/day for nine years. Average prices in PFPB were higher than those in the DLOG series, with a downward trend over the years, narrowing to 2.7 times in 2017, when compared to 2009. Conclusions: Brazil evidenced a moderately sustainable and effective, albeit imperfect, policy for public provision of traditional insulins in the period preceding mandatory free supply of insulin analogues. Future studies must address treatment availability and financial sustainability in the new scenario.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.14321451.v1(source: https://scielo.figshare.com/articles/dataset/Public_financing_of_human_insulins_in_Brazil_2009-2017/14321451)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




